• DSHS HIV/STD Program

    Post Office Box 149347, MC 1873
    Austin, Texas 78714

    Phone: (512) 533-3000

    E-mail the HIV/STD Program

    E-mail data requests to HIV/STD Program - This email can be used to request data and statistics on HIV, TB, and STDs in Texas. It cannot be used to get treatment or infection history for individuals, or to request information on programs and services. Please do not include any personal, identifying health information in your email such as HIV status, Date of Birth, Social Security Number, etc.

    For treatment/testing history, please contact your local Health Department.

    For information on HIV testing and services available to Persons Living with HIV and AIDS, please contact your local HIV services organization.

Epi Profile Section 7 - Focused and Routine HIV Testing


Table 7-1a. DSHS Funded Focused Testing in Texas, 2016

Focused Testing

Tests

%

Positive

% Positive

True New

% True New

48,487

100%

764

1.6%

550

1.1%

Sex

Male

32,678

67%

684

2.1%

504

1.5%

Female

15,788

33%

80

0.5%

46

0.3%

Unknown

21

0%

0

0%

0

0%

Race

White

11,273

23%

140

1.2%

106

0.9%

Black

15,597

32%

314

2.0%

196

1.3%

Hispanic

18,619

38%

271

1.5%

216

1.2%

Other

1,906

4%

29

1.5%

25

1.3%

Unknown

1,092

2%

10

0.9%

7

0.6%

Age Group

0-14 years

53

<1%

1

1.9%

0

0%

15-24 years

14,248

29%

206

1.4%

161

1.1%

25-34 years

17,737

37%

336

1.9%

250

1.4%

35-44 years

8,268

17%

103

1.3%

68

0.8%

45 + years

8,173

17%

103

1.3%

68

0.8%

Unknown

8

0%

0

0%

0

0%

Geography

Austin TGA

4,289

9%

41

1.0%

35

0.8%

Dallas EMA

12,485

26%

287

2.3%

197

1.6%

Fort Worth TGA

4,896

10%

110

2.2%

70

1.4%

Houston EMA

4,543

9%

76

1.7%

58

1.3%

San Antonio TGA

8,833

18%

105

1.2%

72

0.8%

Rest of Texas

13,441

28%

145

1.1%

118

0.9%

Reported Risk

MSM/PWID

509

1%

24

4.7%

15

2.9%

MSM

17,808

37%

567

3.2%

437

2.5%

PWID

2,543

5%

14

0.6%

10

0.4%

Hetero

26,321

54%

153

0.6%

87

0.3%

Non-targeted

1,215

3%

5

0.4%

1

0.1%

Unknown

91

<1%

1

1.1%

0

0%

Table 7-1b. DSHS Funded Routine Testing in Texas, 2016

Routine Testing

Tests

%

Positive

% Positive

True New

% True New

170,659

100%

1,354

0.8%

296

0.2%

Sex

Male

74,706

44%

1,082

1.4%

219

0.3%

Female

95,945

56%

272

0.3%

77

0.1%

Unknown

8

0%

0

0%

0

0%

Race

White

44,320

26%

305

0.7%

55

0.1%

Black

48,672

29%

749

1.5%

139

0.3%

Hispanic

66,660

39%

253

0.4%

93

0.1%

Other

7,300

4%

22

0.3%

4

0.1%

Unknown

3,440

2%

25

0.7%

5

0.1%

Age Group

0-14 years

959

<1%

1

0.1%

0

0%

15-24 years

34,347

20%

146

0.4%

59

0.2%

25-34 years

37,441

22%

396

1.1%

97

0.3%

35-44 years

32,236

19%

324

1.0%

56

0.2%

45 + years

65,665

39%

487

0.7%

84

0.1%

Unknown

11

0%

0

0%

0

0%

Geography

Austin TGA

39,604

23%

176

0.4%

40

0.1%

Dallas EMA

33,255

20%

295

0.9%

90

0.3%

Fort Worth TGA

47,149

28%

247

0.5%

86

0.2%

Houston EMA

27,324

16%

514

1.9%

62

0.2%

San Antonio TGA

14,193

8%

112

0.8%

14

0.1%

Rest of Texas

9,134

5%

10

0.1%

4

<0.1%

Reported Risk

MSM/PWID

10

0%

4

40%

1

10%

MSM

472

<1%

65

13.8%

26

5.5%

PWID

131

<1%

9

6.9%

3

2.3%

Hetero

35,298

21%

570

1.6%

83

0.2%

Non-targeted

488

<1%

18

3.7%

1

0.2%

Unknown

134,260

79%

688

0.5%

182

0.1%

Table 7-1c. DSHS Funded Testing in Texas, 2016

Total Testing

Tests

%

Positive

% Positive

True New

% True New

219,146

100%

2,118

1.0%

846

0.4%

Sex

Male

107,384

49%

1,766

1.6%

726

0.7%

Female

111,733

51%

352

0.3%

123

0.1%

Unknown

29

0%

0

0%

0

0%

Race

White

55,593

25%

445

0.8%

161

0.3%

Black

64,536

29%

1,063

1.6%

335

0.5%

Hispanic

85,279

39%

524

0.6%

29

0.3%

Other

9,206

4%

51

0.6%

29

0.3%

Unknown

4,532

2%

35

0.8%

12

0.3%

Age Group

0-14 years

1,012

1%

2

0.2%

0

0%

15-24 years

48,595

22%

352

0.7%

220

0.5%

25-34 years

55,178

25%

732

1.3%

347

0.6%

35-44 years

40,504

19%

442

1.1%

127

0.3%

45 + years

73,838

34%

590

0.8%

152

0.2%

Unknown

19

0%

0

0%

0

0%

Geography

Austin TGA

43,893

20%

217

0.5%

75

0.2%

Dallas EMA

45,740

21%

582

1.3%

287

0.6%

Fort Worth TGA

52,045

24%

357

0.7%

156

0.3%

Houston EMA

31,867

15%

590

1.9%

120

0.4%

San Antonio TGA

23,026

11%

217

0.9%

86

0.4%

Rest of Texas

22,575

10%

155

0.7%

122

0.5%

Reported Risk

MSM/PWID

519

<1%

28

5.4%

16

3.1%

MSM

18,280

8%

632

3.5%

463

2.5%

PWID

2,674

1%

23

0.9

13

0.5%

Hetero

61,619

28%

723

1.2%

170

0.3%

Non-targeted

1,703

1%

23

1.4%

2

0.1%

Unknown

134,351

61%

689

0.5%

182

0.1%

  • DSHS funds two types of HIV testing efforts. Focused testing sites offer HIV testing to persons at highest risk for HIV, such as MSM. Routine testing is offered as part of other medical care, such as during an emergency room visit for an unrelated health event.

  • Risk information is not typically collected on persons who receive routine HIV testing.

  • The highest HIV positivity rates were found in populations with the highest prevalence rates of HIV, including Blacks, MSM, and MSM/PWID.

  • Persons who tested positive through the focused and routine programs were matched to HIV Surveillance data to determine if they are true new diagnoses or previous positives. A true new positive was an individual whose focused or routine testing event was within 14 days of their official HIV diagnosis date.

  • Overall, the highest diagnosis (true new positive) rates were found among Blacks, MSM and MSM/PWID.


Epi Profile

Table of Contents | 1. Executive Summary | 2. New HIV Diagnoses | 3. Persons Living with HIV | 4. Co-Morbidities | 5. HIV/AIDS Deaths | 6. HIV Incidence | 7. Focused and Routine HIV Testing | 8. Indicators of HIV Risk in HIV-negative Persons at High Risk for HIV | 9. Indicators of HIV Risk in PLWH Currently in Care | 10. Men Who Have Sex With Men (MSM) | 11. HIV Treatment Cascade | Data Sources and Notes


Last updated December 21, 2017